Skip to content
Thursday, February 5, 2026

BLK ALERTS

THE ARCHIVES

  • Home
  • Lifestyle
  • News
  • Crime
  • Entertainment
  • Opinion
  • Sports
  • Politics

FDA faces backlash over approval of genetic test for opioid addiction risk

Posted on April 5, 2024 by blkalertshealth
The Food and Drug Administration is facing backlash over its approval of a genetic test intended to determine if a person is at increased risk for opioid addiction.
Posted in HealthTagged Black Health, black people health, blacknews, CNN, nbcnews, newswirelink, TIME, us health

Post navigation

Previous: Should you be worried about the bird flu? What experts say after Texas case
Next: Growing demand for stronger marijuana highlights the risk of cannabis-induced psychiatric disorders

Related Posts

  • Health

How a network of abortion pill providers works together in the wake of new threats

  • blkalertshealth
  • April 8, 2024
  • 0

As the Supreme Court decides whether to allow acce

  • Coronavirus
  • Health

Denver children’s museum closes temporarily after anger at its mask policy

  • UNR Newswire
  • June 13, 2022
  • 0

The Children’s Museum of Denver said tha

  • Health

Worsening allergies tied to climate change and severe weather

  • blkalertshealth
  • April 19, 2024
  • 0

As doctors report more severe allergy symptoms in

New Comments

  • First Bullet Train Line Approved to Enter Service – BossFM Digital on First Bullet Train Line Approved to Enter Service
  • US Admitting Asylum Seekers, No Longer Enforcing “Remain in Mexico” Program – BossFM Digital on US Admitting Asylum Seekers, No Longer Enforcing “Remain in Mexico” Program
  • Moratorium Ending, Millions Face Eviction – BossFM Digital on Moratorium Ending, Millions Face Eviction
  • Journal of Neuroscience Study Finds Psychological Importance of Face-to-Face Interaction – BossFM Digital on Journal of Neuroscience Study Finds Psychological Importance of Face-to-Face Interaction
Copyright © 2026 BLK ALERTS Theme: Classy News By Adore Themes.